HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.

AbstractBACKGROUND:
The purpose of this study was to assess the relationship between [(18) F]-fluorodeoxyglucose ((18) FDG)-positron emission tomography/CT ((18) FDG-PET/CT) and serum thyroglobulin (Tg) in patients with recurrent differentiated thyroid carcinoma (DTC).
METHODS:
Forty-two patients with recurrent DTC and negative Tg antibodies were included in the study. All patients underwent (131) I therapy due to an increasing serum Tg with a corresponding negative (131) I posttreatment whole body scan. The (18) FDG-PET/CT scans were then performed on all patients, serum Tg was measured concurrently, and respective results were compared.
RESULTS:
Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of the (18) FDG-PET/CT examination were 93%, 84%, 93%, 84%, and 90%, respectively. The sensitivity of (18) FDG-PET/CT significantly increased in patients with serum Tg levels ≥4.6 ng/mL (96%) in comparison with patients having lower levels (25%; p < .001). Nonetheless, 3 of 27 patients (11%) with a true-positive (18) FDG-PET/CT still had a Tg <4.6 ng/mL.
CONCLUSION:
Although (18) FDG-PET/CT scans are more likely to be positive with pretest Tg levels ≥4.6 ng/mL, 11% of patients with DTC with a lower serum Tg level will still have a positive scan. Our findings are in contrast with the American Thyroid Association (ATA) guidelines, which only recommend to perform (18) FDG-PET/CT in patients with Tg levels >10 ng/mL.
AuthorsLuca Giovanella, Luca Ceriani, Diego De Palma, Sergio Suriano, Massimo Castellani, Frederik A Verburg
JournalHead & neck (Head Neck) Vol. 34 Issue 5 Pg. 626-31 (May 2012) ISSN: 1097-0347 [Electronic] United States
PMID21850699 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Wiley Periodicals, Inc.
Chemical References
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Thyroglobulin
Topics
  • Adenocarcinoma, Follicular (diagnostic imaging, therapy)
  • Adult
  • Aged
  • Carcinoma, Papillary (diagnostic imaging, therapy)
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Iodine Radioisotopes (therapeutic use)
  • Lymphatic Metastasis (diagnosis)
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Neoplasm Recurrence, Local (diagnosis)
  • Positron-Emission Tomography
  • Predictive Value of Tests
  • ROC Curve
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Thyroglobulin (blood)
  • Thyroid Neoplasms (diagnostic imaging, therapy)
  • Tomography, X-Ray Computed
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: